3.22.2 html 161 345 1 false 47 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://silopharma.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets Sheet http://silopharma.com/role/ConsolidatedBalanceSheet Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://silopharma.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://silopharma.com/role/ConsolidatedIncomeStatement Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited) Sheet http://silopharma.com/role/ShareholdersEquityType2or3 Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://silopharma.com/role/ConsolidatedCashFlow Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Organization and Business Sheet http://silopharma.com/role/OrganizationandBusiness Organization and Business Notes 7 false false R8.htm 007 - Disclosure - Summary of Significant Accounting Policies Sheet http://silopharma.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements Sheet http://silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurements Fair Value of Financial Instruments and Fair Value Measurements Notes 9 false false R10.htm 009 - Disclosure - Disposal of the Discontinued Operations of the NFID Business Sheet http://silopharma.com/role/DisposaloftheDiscontinuedOperationsoftheNFIDBusiness Disposal of the Discontinued Operations of the NFID Business Notes 10 false false R11.htm 010 - Disclosure - Notes Receivable Notes http://silopharma.com/role/NotesReceivable Notes Receivable Notes 11 false false R12.htm 011 - Disclosure - Stockholders??? Equity Sheet http://silopharma.com/role/StockholdersEquity Stockholders??? Equity Notes 12 false false R13.htm 012 - Disclosure - Concentrations Sheet http://silopharma.com/role/Concentrations Concentrations Notes 13 false false R14.htm 013 - Disclosure - Commitments and Contingencies Sheet http://silopharma.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 14 false false R15.htm 014 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://silopharma.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://silopharma.com/role/SummaryofSignificantAccountingPolicies 15 false false R16.htm 015 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://silopharma.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://silopharma.com/role/SummaryofSignificantAccountingPolicies 16 false false R17.htm 016 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements (Tables) Sheet http://silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurementsTables Fair Value of Financial Instruments and Fair Value Measurements (Tables) Tables http://silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurements 17 false false R18.htm 017 - Disclosure - Disposal of the Discontinued Operations of the NFID Business (Tables) Sheet http://silopharma.com/role/DisposaloftheDiscontinuedOperationsoftheNFIDBusinessTables Disposal of the Discontinued Operations of the NFID Business (Tables) Tables http://silopharma.com/role/DisposaloftheDiscontinuedOperationsoftheNFIDBusiness 18 false false R19.htm 018 - Disclosure - Notes Receivable (Tables) Notes http://silopharma.com/role/NotesReceivableTables Notes Receivable (Tables) Tables http://silopharma.com/role/NotesReceivable 19 false false R20.htm 019 - Disclosure - Stockholders??? Equity (Tables) Sheet http://silopharma.com/role/StockholdersEquityTables Stockholders??? Equity (Tables) Tables http://silopharma.com/role/StockholdersEquity 20 false false R21.htm 020 - Disclosure - Commitments and Contingencies (Tables) Sheet http://silopharma.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://silopharma.com/role/CommitmentsandContingencies 21 false false R22.htm 021 - Disclosure - Organization and Business (Details) Sheet http://silopharma.com/role/OrganizationandBusinessDetails Organization and Business (Details) Details http://silopharma.com/role/OrganizationandBusiness 22 false false R23.htm 022 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://silopharma.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://silopharma.com/role/SummaryofSignificantAccountingPoliciesTables 23 false false R24.htm 023 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of anti-dilutive net loss per share Sheet http://silopharma.com/role/ScheduleofantidilutivenetlosspershareTable Summary of Significant Accounting Policies (Details) - Schedule of anti-dilutive net loss per share Details http://silopharma.com/role/SummaryofSignificantAccountingPoliciesTables 24 false false R25.htm 024 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements (Details) Sheet http://silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurementsDetails Fair Value of Financial Instruments and Fair Value Measurements (Details) Details http://silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurementsTables 25 false false R26.htm 025 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements (Details) - Schedule of assets and liabilities measured at fair value on a recurring basis Sheet http://silopharma.com/role/ScheduleofassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable Fair Value of Financial Instruments and Fair Value Measurements (Details) - Schedule of assets and liabilities measured at fair value on a recurring basis Details http://silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurementsTables 26 false false R27.htm 026 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements (Details) - Schedule of activity in the company???s equity investments, at fair value Sheet http://silopharma.com/role/ScheduleofactivityinthecompanysequityinvestmentsatfairvalueTable Fair Value of Financial Instruments and Fair Value Measurements (Details) - Schedule of activity in the company???s equity investments, at fair value Details http://silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurementsTables 27 false false R28.htm 027 - Disclosure - Disposal of the Discontinued Operations of the NFID Business (Details) Sheet http://silopharma.com/role/DisposaloftheDiscontinuedOperationsoftheNFIDBusinessDetails Disposal of the Discontinued Operations of the NFID Business (Details) Details http://silopharma.com/role/DisposaloftheDiscontinuedOperationsoftheNFIDBusinessTables 28 false false R29.htm 028 - Disclosure - Disposal of the Discontinued Operations of the NFID Business (Details) - Schedule of financial data of the company???s gain from sale of the NFID business Sheet http://silopharma.com/role/ScheduleoffinancialdataofthecompanysgainfromsaleoftheNFIDbusinessTable Disposal of the Discontinued Operations of the NFID Business (Details) - Schedule of financial data of the company???s gain from sale of the NFID business Details http://silopharma.com/role/DisposaloftheDiscontinuedOperationsoftheNFIDBusinessTables 29 false false R30.htm 029 - Disclosure - Disposal of the Discontinued Operations of the NFID Business (Details) - Schedule of operating result of discontinued operations of the NFID business Sheet http://silopharma.com/role/ScheduleofoperatingresultofdiscontinuedoperationsoftheNFIDbusinessTable Disposal of the Discontinued Operations of the NFID Business (Details) - Schedule of operating result of discontinued operations of the NFID business Details http://silopharma.com/role/DisposaloftheDiscontinuedOperationsoftheNFIDBusinessTables 30 false false R31.htm 030 - Disclosure - Notes Receivable (Details) Notes http://silopharma.com/role/NotesReceivableDetails Notes Receivable (Details) Details http://silopharma.com/role/NotesReceivableTables 31 false false R32.htm 031 - Disclosure - Notes Receivable (Details) - Schedule of notes receivable net Notes http://silopharma.com/role/ScheduleofnotesreceivablenetTable Notes Receivable (Details) - Schedule of notes receivable net Details http://silopharma.com/role/NotesReceivableTables 32 false false R33.htm 032 - Disclosure - Stockholders??? Equity (Details) Sheet http://silopharma.com/role/StockholdersEquityDetails Stockholders??? Equity (Details) Details http://silopharma.com/role/StockholdersEquityTables 33 false false R34.htm 033 - Disclosure - Stockholders??? Equity (Details) - Schedule of stock options activities Sheet http://silopharma.com/role/ScheduleofstockoptionsactivitiesTable Stockholders??? Equity (Details) - Schedule of stock options activities Details http://silopharma.com/role/StockholdersEquityTables 34 false false R35.htm 034 - Disclosure - Stockholders??? Equity (Details) - Schedule of warrant activities Sheet http://silopharma.com/role/ScheduleofwarrantactivitiesTable Stockholders??? Equity (Details) - Schedule of warrant activities Details http://silopharma.com/role/StockholdersEquityTables 35 false false R36.htm 035 - Disclosure - Concentrations (Details) Sheet http://silopharma.com/role/ConcentrationsDetails Concentrations (Details) Details http://silopharma.com/role/Concentrations 36 false false R37.htm 036 - Disclosure - Commitments and Contingencies (Details) Sheet http://silopharma.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://silopharma.com/role/CommitmentsandContingenciesTables 37 false false R38.htm 037 - Disclosure - Commitments and Contingencies (Details) - Schedule of milestone payments Sheet http://silopharma.com/role/ScheduleofmilestonepaymentsTable Commitments and Contingencies (Details) - Schedule of milestone payments Details http://silopharma.com/role/CommitmentsandContingenciesTables 38 false false R39.htm 038 - Disclosure - Commitments and Contingencies (Details) - Schedule of UMB minimum royalty payments Sheet http://silopharma.com/role/ScheduleofUMBminimumroyaltypaymentsTable Commitments and Contingencies (Details) - Schedule of UMB minimum royalty payments Details http://silopharma.com/role/CommitmentsandContingenciesTables 39 false false R40.htm 039 - Disclosure - Commitments and Contingencies (Details) - Schedule of shall pay UMB fees Sheet http://silopharma.com/role/ScheduleofshallpayUMBfeesTable Commitments and Contingencies (Details) - Schedule of shall pay UMB fees Details http://silopharma.com/role/CommitmentsandContingenciesTables 40 false false All Reports Book All Reports f10q0622_silopharma.htm f10q0622ex31-1_silopharma.htm f10q0622ex32-1_silopharma.htm silo-20220630.xsd silo-20220630_cal.xml silo-20220630_def.xml silo-20220630_lab.xml silo-20220630_pre.xml http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true